Dimethaid to resubmit arthritis drug to FDA by mid-2006; expects approval

TORONTO (CP) - Dimethaid Research Inc. said Monday it expects the arthritis pain-treating lotion Pennsaid, its great hope to capitalize on an arthritis drug vacuum after the U.S. withdrawal of Vioxx, will be resubmitted to the FDA for approval by the middle of next year....More